Scholarlink

Purpose of Review <p>High density lipoprotein (HDL) has historically been considered cardioprotective, with HDL cholesterol (HDL-C) levels widely used as a biomarker of cardiovascular disease risk. However, accumulating evidence suggests that HDL-C concentration alone does not adequately capture the complex biological functions of HDL particles. This review revisits the evolving understanding of HDL biology and examines the emerging importance of HDL functionality, particle size and particle number in cardiometabolic risk assessment. It further highlights recent methodological advances that enable more detailed characterization of HDL heterogeneity.&#xa0;</p> Recent Findings <p> Contemporary research demonstrates that HDL represents a structurally and functionally heterogenous group of particles with diverse biological activities. Cardioprotective effects attributed to HDL are increasingly linked to functional properties rather than to HDL-C levels alone. Growing evidence suggest that HDL particle concentration and subclass distribution may correlate more strongly with cardiovascular outcomes than conventional HDL-C measurements. Technological advances, such as nuclear magnetic resonance(NMR) spectroscopy and polyacrylamide gel electrophoresis based systems like the Lipoprint platform, now allow more precise quantification and classification of HDL subfractions.&#xa0;</p> Summary <p> Current evidence challenges the traditional reliance on HDL-C as a surrogate marker of cardiovascular protection. Instead, HDL should be viewed as a dynamic and heterogenous lipoprotein system in which particle characteristics and functional capacity are critical determinants of cardiometabolic risk. Incorporating measurement of HDL particle distribution and functionality into research and clinical evaluation may improve cardiovascular risk stratification and deepen understanding of HDL biology. Continued advances in analytical technologies and functional assays are likely to reshape HDL assessment and support more precise, mechanism based approaches to cardiovascular disease prevention and management.&#xa0;</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

High Density Lipoprotein Assessment Revisited: A Review of Foundational Understanding and Recent Developments in Function, Particle Size, and Cardiometabolic Impact

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Anita Sherly A,
  • Rukmini Mysore Srikantiah,
  • Anand Rohatgi,
  • Anupama Hegde,
  • Sindhu H,
  • Arun S

摘要

Purpose of Review

High density lipoprotein (HDL) has historically been considered cardioprotective, with HDL cholesterol (HDL-C) levels widely used as a biomarker of cardiovascular disease risk. However, accumulating evidence suggests that HDL-C concentration alone does not adequately capture the complex biological functions of HDL particles. This review revisits the evolving understanding of HDL biology and examines the emerging importance of HDL functionality, particle size and particle number in cardiometabolic risk assessment. It further highlights recent methodological advances that enable more detailed characterization of HDL heterogeneity. 

Recent Findings

Contemporary research demonstrates that HDL represents a structurally and functionally heterogenous group of particles with diverse biological activities. Cardioprotective effects attributed to HDL are increasingly linked to functional properties rather than to HDL-C levels alone. Growing evidence suggest that HDL particle concentration and subclass distribution may correlate more strongly with cardiovascular outcomes than conventional HDL-C measurements. Technological advances, such as nuclear magnetic resonance(NMR) spectroscopy and polyacrylamide gel electrophoresis based systems like the Lipoprint platform, now allow more precise quantification and classification of HDL subfractions. 

Summary

Current evidence challenges the traditional reliance on HDL-C as a surrogate marker of cardiovascular protection. Instead, HDL should be viewed as a dynamic and heterogenous lipoprotein system in which particle characteristics and functional capacity are critical determinants of cardiometabolic risk. Incorporating measurement of HDL particle distribution and functionality into research and clinical evaluation may improve cardiovascular risk stratification and deepen understanding of HDL biology. Continued advances in analytical technologies and functional assays are likely to reshape HDL assessment and support more precise, mechanism based approaches to cardiovascular disease prevention and management.